MedTrace Logo

Maintenance Plasma Exchange for Neuromyelitis Optica

NCT01500681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-12-27

No results posted yet for this study

Summary

Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is associated with autoantibodies to aquaporin-4. Treatment options for prevention of clinical relapses of NMO include immunosuppressive medications. Plasma exchange (PLEX) is commonly used as a rescue therapy for NMO relapses but ongoing, regular PLEX procedures (maintenance PLEX) is sometimes used to prevent relapses. This observational registry will record feasibility, tolerability, safety, and preliminary efficacy data regarding maintenance PLEX for NMO.

Conditions

Interventions

PROCEDURE

Plasma exchange (PLEX)

Regular maintenance PLEX courses, typically 3 procedures monthly

Sponsors & Collaborators

  • Terumo BCT

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Dean M Wingerchuk, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-07-09
Completion
2015-07-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500681 on ClinicalTrials.gov